Department of Digestive Surgery, Nihon University School of Medicine, 30-1, Oyaguchikami-machi, Itabashi-ku, Tokyo, 173-8610, Japan.
Department of General Surgery, National Center of Neurology and Psychiatry, Tokyo, 187-8551, Japan.
World J Surg. 2022 May;46(5):1134-1140. doi: 10.1007/s00268-022-06453-9. Epub 2022 Feb 4.
We aimed to validate our algorithm for resecting Hepatocellular carcinoma (HCC) in the caudate lobe based on tumor location, tumor size, and indocyanine green clearance rate.
Patients who underwent curative resections for solitary HCC in the caudate lobe were included. The surgical outcomes of patients with HCC in the caudate lobe were compared with those of patients with HCC in other sites of the liver.
After one-to-one matching, the caudate-lobe group (n = 150) had longer operation time, greater amount of bleeding, lower weight of resected specimens, and shorter distance between tumor and resection line than the other-sites group (n = 150), but the complication rates were not different between the groups (38.0% vs. 34.1%, P = 0.719). After a median follow-up period of 3.0 years (range, 0.3-16.2 years), the median overall survivals were 6.5 (95% confidence interval [CI], 5.3-7.9) and 7.5 years (95% CI, 6.3-9.7) in the caudate-lobe and other-site groups, respectively (P = 0.430). Median recurrence-free survivals in the caudate-lobe group (1.9 years; 95% CI, 1.4-2.7) had a tendency to be shorter than those in the other-sites group (2.3 years; 1.7-3.4) (P = 0.052).
Patients' survival and complication rates in the caudate-lobe group were comparable to those in the other-sites group; therefore, our algorithm for resecting HCC in the caudate lobe is of clinical use.
我们旨在验证我们基于肿瘤位置、肿瘤大小和吲哚菁绿清除率来切除肝尾状叶肝细胞癌(HCC)的算法。
纳入接受肝尾状叶单发 HCC 根治性切除术的患者。比较肝尾状叶 HCC 患者与其他肝部位 HCC 患者的手术结果。
经过一对一匹配,尾状叶组(n=150)的手术时间更长、出血量更大、切除标本重量更轻、肿瘤与切除线之间的距离更短,而两组的并发症发生率无差异(38.0% vs. 34.1%,P=0.719)。中位随访 3.0 年(范围,0.3-16.2 年)后,尾状叶组和其他部位组的中位总生存率分别为 6.5(95%可信区间,5.3-7.9)和 7.5 年(95%可信区间,6.3-9.7)(P=0.430)。尾状叶组的中位无复发生存率(1.9 年;95%可信区间,1.4-2.7)短于其他部位组(2.3 年;1.7-3.4)(P=0.052)。
尾状叶组患者的生存和并发症发生率与其他部位组相当;因此,我们用于切除肝尾状叶 HCC 的算法具有临床应用价值。